Volume: | 74,353 |
Day Range: | 4.75 - 5.00 |
Bid: | 4.82 |
Ask: | 4.94 |
Last Trade Time: | 12:57:43 PM EST |
Total Trades: | 733 |
Recent DTIL News
- Precision BioSciences Announces Complete Clinical Response in First Infant Dosed by Partner iECURE in Ongoing Phase 1/2 Clinical Trial in Ornithine Transcarbamylase (OTC) Deficiency • Business Wire • 01/09/2025 03:01:00 PM
- iECURE Reports Complete Clinical Response in First Infant Dosed with its In Vivo Gene Editing Candidate ECUR-506 in an Ongoing Phase 1/2 Clinical Trial in Ornithine Transcarbamylase (OTC) Deficiency • Business Wire • 01/09/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2025 01:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 12:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/31/2024 12:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/31/2024 12:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2024 11:10:39 AM
- Precision BioSciences Receives Approval in Hong Kong to Expand PBGENE-HBV Phase 1 ELIMINATE-B Trial for the Treatment of Chronic Hepatitis B • Business Wire • 12/18/2024 12:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2024 09:30:07 PM
- Precision BioSciences to Participate in Upcoming November Investor Conferences • Business Wire • 11/21/2024 12:01:00 PM
- Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B • Business Wire • 11/15/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2024 12:14:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2024 12:14:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2024 12:14:05 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/04/2024 08:51:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/04/2024 08:49:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 12:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 12:15:08 PM
- Precision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update • Business Wire • 11/04/2024 12:01:00 PM
- Precision BioSciences to Report Third Quarter Results on November 4, 2024 • Business Wire • 10/29/2024 11:01:00 AM
- Precision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HBV Preclinical Safety Data and Phase 1 Clinical Trial Plans on November 15, 2024 • Business Wire • 10/28/2024 11:01:00 AM
- Precision BioSciences Presents Preclinical Data Highlighting the Capability of ARCUS for High-Efficiency Gene Editing Utilizing Homology-Directed Repair at the ESGCT 31st Annual Congress • Business Wire • 10/24/2024 08:15:00 PM
- Precision BioSciences Receives First Approval of Clinical Trial Application to Initiate PBGENE-HBV First-In-Human Study for the Treatment of Chronic Hepatitis B • Business Wire • 10/24/2024 12:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 12:45:07 PM
- Precision BioSciences to Participate in Upcoming Longwood Boston CEO and Guggenheim Healthcare Conferences • Business Wire • 10/21/2024 11:01:00 AM
FEATURED Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM